ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 2836
    Early Clinical Response Is a Better Predictor of Long-Term Remission Than Baseline Disease Characteristics Following Adalimumab Treatment in Peripheral Spondyloarthritis
  • Abstract Number: 557
    Early Intensification of Treatment Induces Superior Outcomes in Two Randomized Trials According to Predicted Vs. Observed Radiographic Progression in Rheumatoid Arthritis
  • Abstract Number: 1638
    Early Response As a Predictor of Long-Term Remission in DMARD-Naïve Patients with Severe, Active and Progressive Rheumatoid Arthritis Treated with Certolizumab Pegol in Combination with Methotrexate
  • Abstract Number: 1948
    Early Rheumatoid Arthritis Patients Have Higher Fractions of Circulating Th2 Cells, Th17 Cells and Regulatory T Cells, Similar Fractions of Follicular Helper T Cells, and Lower Fractions of Th17/Th1 Cells and Th1 Cells Compared to Healthy Controls
  • Abstract Number: 487
    Early Rheumatoid Arthritis Patients in the Worse Disease Trajectory Group Fail to Achieve Improvement in Physical Function
  • Abstract Number: 1896
    Early Signs, Symptoms and Auto-Antibodies to Predict Diffuse Cutaneous or Limited Cutaneous Systemic Sclerosis at First Presentation
  • Abstract Number: 730
    Early Symptoms of Systemic Lupus Erythematosus As Reported By Members of the German Lupus Erythematosus Patient Association
  • Abstract Number: 128
    Economic Burden and Treatment Patterns of Cycling Between Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) Among Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 2243
    Economic Burden of Controlled Gout, Uncontrolled Gout, and Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
  • Abstract Number: 301
    Economic Burden of Sporadic Inclusion Body Myositis in the United States of America: A Retrospective Cohort Study
  • Abstract Number: 145
    Economic Burden of Switching to an Anti-Tumor Necrosis Factor (anti-TNF) Versus a Non-Tumor Necrosis Factor (non-TNF) Biologic Therapy Among Patients with Rheumatoid Arthritis
  • Abstract Number: 989
    Economic Evaluation of Lupus Nephritis in an International Inception Cohort: Comparing the Hospitalization, Medication, Dialysis, and Procedure Costs of Those with and without Nephritis
  • Abstract Number: 598
    Economic Impact of Decreasing Adalimumab and Etanercept Doses and Drug Monitoring in Patients with Rheumatoid Arthritis in Clinical Remission: Preliminary Study from a Local Biologics Unit
  • Abstract Number: 963
    Ectopic Lymphoid Tissue in the Lung Is Associated with Serum Rheumatoid Arthritis-Related Autoantibodies Even in Absence of Clinically Apparent Rheumatoid Arthritis
  • Abstract Number: 1178
    Educational Impact of a Clinical Anatomy Workshop on 1st-Year Orthopedic and Rheumatology Fellows and a Comparison of Scores Between Specialties in Mexico
  • Abstract Number: 1311
    Effect of a Non Biologic Treat-to-Target Strategy on MRI-Determined Inflammatory and Destructive Changes in Early Rheumatoid Arthritis – Results from a 2-Year Investigator-Initiated Double-Blind Randomized Controlled Clinical Trial
  • Abstract Number: 2733
    Effect of Abatacept on Telomerase Activity of Lymphocytes of Patients with Rheumatoid Arthritis
  • Abstract Number: 2039
    Effect of Adalimumab on Visual Functioning (VFQ-25) in Visual-1 Trial Patients with Non-Anterior Non-Infectious Uveitis
  • Abstract Number: 3172
    Effect of Anti Citrullinated Protein Antibodies on Periarticular and Systemic Bone Mass in Early Arthritis Patients
  • Abstract Number: 2668
    Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate
  • Abstract Number: 1576
    Effect of Conventional Synthetic and Biological Disease Modifying Anti-Rheumatic Drugs on the Immunogenicity of Hepatitis B Vaccine in Patients with Rheumatoid Arthritis
  • Abstract Number: 1553
    Effect of Drug Therapy on Net Cholesterol Efflux Capacity of HDL-Enriched Serum in Rheumatoid Arthritis
  • Abstract Number: 6L
    Effect of Interleukin-17A Inhibition on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of a Phase 3 Study with Secukinumab
  • Abstract Number: 1640
    Effect of Methotrexate Dose on the Efficacy of Tofacitinib: Treatment Outcomes from a Phase 3 Clinical Trial of Patients with Rheumatoid Arthritis
  • Abstract Number: 1144
    Effect of PEP-1-Glrx-1 on Catabolic Gene Expression in Human Articular Chondrocytes and in Mouse Carrageenan-Induced Paw Edema Model
  • Abstract Number: 2579
    Effect of Tacrolimus on Endoplasmic Reticulum Stress-Mediated Osteoclastogenesis in a Collagen-Induced Arthritis Mouse Model
  • Abstract Number: 2919
    Effect of Thrombotic Microangiopathy on Clinical Outcomes in LUPUS Nephritis
  • Abstract Number: 1537
    Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis
  • Abstract Number: 266
    Effect of Tocilizumab on Adults Onset Still’s Disease in Korean Population: Multicenter Retrospecitve Study of 24 Cases
  • Abstract Number: 1088
    Effect of Training on Knee Torsional Stiffness and Its Relationship to Tibial Compressive and Anterior Shear Forces in Recreational Female Runners
  • Abstract Number: 316
    Effect of Vitamin D on Effusion-Synovitis in Knee Osteoarthritis:  a Randomized Controlled Trial
  • Abstract Number: 2859
    Effect of Weight on Efficacy of Certolizumab Pegol in Patients with Axial Spondyloarthritis
  • Abstract Number: 2006
    Effect Size of the Anti-Aggrecanase-2 Monoclonal Antibody CRB0017 in Rodent Models of Osteoarthritis
  • Abstract Number: 1180
    Effective Knowledge Transfer: A Demonstration of Video Illustration in the Immunology Curriculum for Rheumatology Trainees
  • Abstract Number: 2871
    Effectiveness and Safety of Golimumab in the Treatment of Ankylosing Spondylitis over a 12 Month Period
  • Abstract Number: 2866
    Effectiveness and Safety of Golimumab in the Treatment of Psoriatic Arthritis over a 12 Month Period
  • Abstract Number: 2753
    Effectiveness and Safety of Tocilizumab in Biologics-Naive RA Patients – Postmarketing Surveillance for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-Naive RA Patients (FIRST Bio) Study
  • Abstract Number: 953
    Effectiveness of a Progressive Resistence Strength Programme on Hand Osteoarthritis: A Randomized Crontrolled Trial
  • Abstract Number: 2240
    Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate: A Study Using Large Intergrated National Health Network
  • Abstract Number: 320
    Effectiveness of Bracing in Elderly with Knee Osteoartritis: A Randomized Controlled Trial
  • Abstract Number: 2288
    Effectiveness of Dry Needling and Exercise in Dizziness Caused By Cervical Myofascial Pain Syndrome
  • Abstract Number: 1655
    Effectiveness of Monotherapy in Rheumatoid Arthritis (RA) Patients Initiating a Tumor Necrosis Factor Inhibitor (TNFi) Vs a Non-TNFi in a Large US Commercial and Medicare Advantage Plan
  • Abstract Number: 1091
    Effectiveness of Multidisciplinary Pain Rehabilitation Programs for Patients with Fibromyalgia Syndrome: A Systematic Review
  • Abstract Number: 2079
    Effectiveness of Renoprotective Approaches in Lupus Nephritis: More Than Just Immunosuppression
  • Abstract Number: 321
    Effects of Bariatric Surgery on Long-Term Quality of Life Outcomes for Obese Patients with Osteoarthritis
  • Abstract Number: 2237
    Effects of Coffee Consumption on Serum Uric Acid. a Systematic Review and Meta-Analysis
  • Abstract Number: 1491
    Effects of Drug Induced Toxicity on Patient Reported Outcomes in Early Rheumatoid Arthritis Treated-to-Target Using Conventional Triple DMARD Therapy
  • Abstract Number: 216
    Effects of Monosodium Urate Crystals on Mlo-Y4 Cell Viability; Is There a Role for Osteocytes in Erosive Gout?
  • Abstract Number: 2355
    Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet on Serum Uric Acid Levels: A Randomized Controlled Trial
  • Abstract Number: 2489
    Effects of Two Interventions on Rheumatologists Adherence to Optimal Care Recommendations in Rheumatoid Arthritis: A Combined before/after and Randomized Controlled Trial
  • Abstract Number: 2352
    Efficacy and Safety in Patients with Tophaceous Gout Receiving Lesinurad and Febuxostat Combination Therapy: Interim Analysis of an Extension Study
  • Abstract Number: 3219
    Efficacy and Safety of 4 Weeks Administration of Arsenic Trioxide in Moderate Active Systemic Lupus Erythematosus. a Phase I/II Proof-of-Concept Sequential Dose Escalation Multicenter Study
  • Abstract Number: 2428
    Efficacy and Safety of Adalimumab in Adult Patients with Polyarticular Juvenille Idiopathic Arthritis
  • Abstract Number: 2363
    Efficacy and Safety of Adrenocorticotropic Hormone Gel (Acthar Gel ®) in Refractory Dermatomyositis or Polymyositis
  • Abstract Number: 2422
    Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis: Results from the Phase 3 Extension Study
  • Abstract Number: 248
    Efficacy and Safety of Canakinumab in Patients with CAPS Aged <24 Months: Results from an Open-Label, Multicenter, Phase III Trial
  • Abstract Number: 2144
    Efficacy and Safety of Different Dose Regimens of a Selective IL-23p19 Inhibitor (BI 655066) Compared with Ustekinumab in Patients with Moderate-to-Severe Plaque Psoriasis with and without Psoriatic Arthritis
  • Abstract Number: 4L
    Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials
  • Abstract Number: 2350
    Efficacy and Safety of Febuxostat in 55 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Results from a Retrospective Multicenter Study
  • Abstract Number: 1988
    Efficacy and Safety of Mizoribine for Polymyalgia Rheumatica: Analysis of 47 Cases
  • Abstract Number: 3145
    Efficacy and Safety of Modified-Release Prednisone in Patients with Polymyalgia Rheumatica: Results of a Multicenter, Randomized, Active-Controlled Phase 3 Study
  • Abstract Number: 3079
    Efficacy and Safety of Riociguat in Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disease (CTD)
  • Abstract Number: 2058
    Efficacy and Safety of Rituximab Biosimilar Candidate (CT-P10) and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase I Randomized Controlled Trial over 72 Weeks
  • Abstract Number: 970
    Efficacy and Safety of Sarilumab in Combination with Csdmards in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti–TNF-α Therapy: Results from a Phase 3 Study
  • Abstract Number: 2760
    Efficacy and Safety of Sarilumab Plus MTX in Subgroups of Patients with Rheumatoid Arthritis in a Phase 3 Study
  • Abstract Number: 1675
    Efficacy and Safety of Switched CT-P10 from Innovator Rituximab Compared to Those of Maintained CT-P10 in Patients with Rheumatoid Arthritis up to 56 Weeks
  • Abstract Number: 3144
    Efficacy and Safety of Tocilizumab for Polymyalgia Rheumatica
  • Abstract Number: 2742
    Efficacy and Safety of Tofacitinib Monotherapy Versus Combination Therapy in a Latin American Subpopulation of Patients with Rheumatoid Arthritis: A Pooled Phase 3 Analysis
  • Abstract Number: 2856
    Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylarthritis As Well As  Peripheral Arthritis: Results from 2 Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
  • Abstract Number: 1385
    Efficacy and Tolerance of Rituximab in IgG4-Related Disease: A Retrospective Multicentric Study in 24 Patients
  • Abstract Number: 1310
    Efficacy of Abatacept in Patients with Rheumatoid Arthritis Assessed By MRI Scans of Bilateral Hands
  • Abstract Number: 1106
    Efficacy of Abbv-105, a Selective and Irreversible Inhibitor of Bruton’s Tyrosine Kinase (BTK), in Multiple Models of Inflammation
  • Abstract Number: 626
    Efficacy of Belimumab and Targeting of Rheumatoid Factor Positive B-Cells in Sjögren’s Syndrome: Follow-up of the Open-Label Phase II Study
  • Abstract Number: 960
    Efficacy of Canakinumab in Systemic Juvenile Idiopathic Arthritis Patients Previously Exposed to Biologics
  • Abstract Number: 1814
    Efficacy of Isoniazid Chemoprophylaxis in Lupus Nephritis Patients
  • Abstract Number: 2962
    Efficacy of Mycophenolate As a Maintenance Therapy Following the Administration of Cyclophosphamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
  • Abstract Number: 343
    Efficacy of Odanacatib in Postmenopausal Women with Osteoporosis: Subgroup Analyses of Data from the Phase 3 Long-Term Odanacatib Fracture Trial
  • Abstract Number: 2770
    Efficacy of Sarilumab Plus Methotrexate in Achieving Clinical Remission, Using 4 Different Definitions, in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis in a Phase 3 Study
  • Abstract Number: 499
    Efficacy of Tocilizumab Monotherapy in Patients with RA Is Not Influenced By ACPA Positivity
  • Abstract Number: 451
    Efficacy of Tofacitinib in a Real World Setting Using the Database Jointman
  • Abstract Number: 602
    Efficacy of Very Low Dose (100mg) Rituximab in Active Rheumatoid Arthritis Despite Combination DMARD-Single Center, Prospective, Observational Study
  • Abstract Number: 1485
    Efficacy of Yttrium-90 Radiosynovectomy in Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome
  • Abstract Number: 279
    Ehlers-Danlos Syndrome Hypermobility Type (Type III) Is Associated with Rheumatological Conditions
  • Abstract Number: 856
    Elderly Versus Younger Patients with ANCA-Associated Vasculitis
  • Abstract Number: 784
    Electronic Health Record (EHR) As a Powerful Tool to Establish Clinical Research Lupus Cohorts
  • Abstract Number: 1994
    Electronic Patient Reported Outcome Measures in Systemic Lupus Erythematosus : A Potential Disease Modifying Impact on the Management of Disease Activity Flares and Damage Accrual
  • Abstract Number: 2660
    Elevated 14-3-3η Serum Protein Levels Increase RA Confirmation Rates in Recent-Onset Polyarthritis Patients
  • Abstract Number: 523
    Elevated Antibody Response to Porphyromonas Gingivalis Detected in Sera Years before the Clinical Onset of Rheumatoid Arthritis
  • Abstract Number: 2020
    Elevated BMI and ACPA Together Increase RA Risk and Independently Accelerate Time to RA
  • Abstract Number: 2066
    Elevated Innate, Adaptive, and TNF-Superfamily Soluble Inflammatory Mediators Mark Impending Disease Flare, While Regulatory Mediators Distinguish Lack of Impending Disease Flare in African-American SLE Patients with Active Disease
  • Abstract Number: 2796
    Elevated Serum Immunoglobulin G Is a Prognostic Factor for Progression of Interstitial Lung Disease in Primary Sjögren’s Syndrome
  • Abstract Number: 821
    Elevated Serum Levels of Soluble CD146 in Patients with Systemic Sclerosis
  • Abstract Number: 2721
    Elevated Subgingival Levels of Periodontal Pathogens in Rheumatoid Arthritis Patients, Particularly Leptotrichia species in New-Onset Disease
  • Abstract Number: 1526
    Employment and Quality of Life Among Patients with Rheumatoid Arhtritis in Four Latin-American Countries
  • Abstract Number: 1570
    End Stage Renal Disease (ESRD) in Patients with Rheumatoid Arthritis
  • Abstract Number: 3141
    Endothelial Cells Regulate Proinflammatory T Cell Responses in Large Vessel Vasculitis Via NOTCH-NOTCH Ligand Interactions
  • Abstract Number: 2934
    Endothelial Dysfunction in SLE-the Role of Platelets and Type I Interferon
  • Abstract Number: 3014
    Endotrophin: A Novel Adipokine Linking Adipose Tissue and Skin Fibrosis in Systemic Sclerosis
  • Abstract Number: 1498
    Engaging Clinic Staff in Work System Redesign to Adapt a Hypertension Protocol for Rheumatology
  • Abstract Number: 2221
    Engaging Learners in Lupus Education with Pivot (Practice Improvement using Virtual Online Training), a Novel, Digital Case-Based Curriculum
  • Abstract Number: 1938
    Engaging PD-1 Resuscitates Synovial Treg Cells and Dampens the Joint Infiltrating T Cells in Rheumatoid Arthritis
  • Abstract Number: 2829
    Enhanced Expression of the Transcription Factor T-Bet Alters Pro-Inflammatory Cytokine Profile in Ankylosing Spondylitis
  • Abstract Number: 1369
    Enhanced Myelopoiesis Downstream of Toll-like Receptor 9 Activation Drives a Feed-Forward Inflammatory Response
  • Abstract Number: 1605
    Enhanced Oxidant Signaling in Inflammatory Macrophages in Rheumatoid Arthritis (RA) and in Coronary Artery Disease (CAD)
  • Abstract Number: 3189
    Enhancement of Mitochondrial Biogenesis Inhibits Cell Proliferation and MMP-3/RANKL Secretion in Rheumatoid Arthritis Fibroblast-like Synovial Cells and Joint Destruction in Arthritis Model Mice
  • Abstract Number: 1043
    Enhancing Comparative Effectiveness Research By Combining Observational and Randomized Trial Data to Personalize the Choice Between Methotrexate and Triple Therapy for Methotrexate-Naïve Patients with Early Rheumatoid Arthritis
  • Abstract Number: 2226
    Enhancing Medicine Trainees’ Exposure to Common Musculoskeletal Disorders through a Primary Care Musculoskeletal Clinic
  • Abstract Number: 2805
    Enteric Flora in Newly Diagnosed Spondyloarthritis: A Collaborative Study
  • Abstract Number: 1718
    Entheseal Abnormalities and Nail Involvement at the Distal Interphalangeal Joints on Ultrasound Examination in Patients with Psoriasis and Psoriatic Arthritis. Could the Nail-Enthesitis Theory be Supported?
  • Abstract Number: 1711
    Enthesitis in Psoriatic Arthritis – Disease Association and Risk Factors
  • Abstract Number: 1710
    Enthesitis in Psoriatic Arthritis:  Incidence, Prevalence and Characteristics
  • Abstract Number: 893
    Epidemiological Features of Childhood IgA Vasculitis (Henoch-Schönlein) in a French County: A Population-Based Survey
  • Abstract Number: 2884
    Epidemiological Parameters Affecting Therapeutic Response in Psoriatic Arthritis Patients
  • Abstract Number: 1233
    Epidemiology of GCA in Bergen (Western Norway) 1972-2012
  • Abstract Number: 1235
    Epidemiology of Kikuchi-Fujimoto Disease in Martinique and Characteristics in an Afro-Caribbean Population: Close Relation with Lupus
  • Abstract Number: 1234
    Epidemiology of Sarcoidosis 1976-2013: A Population-Based Study
  • Abstract Number: 18
    Epigallocatechin-3-Gallate (EGCG) Facilitates TAK1 Nuclear Translocation and Its Interaction with p300 to Inhibit Histone Acetylation in Human RA Synovial Fibroblasts
  • Abstract Number: 1863
    Epigenetic Changes in SLE Implicate Enhancers As a Force in Pathologic Cell Behavior
  • Abstract Number: 3256
    Epigenetic Chromosome Conformations Predict MTX Responsiveness in Early Rheumatoid Arthritis Patients
  • Abstract Number: 1373
    Epigenetic Mechanisms Contribute to the Lack of LPS-Induced Tolerance in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 1624
    Epigenetic Profiling of CD14+ and CD16+ Monocyte Subtypes in Rheumatoid Arthritis.  Alterations Related to Cardiovascular Disease and Endothelial Dysfunction
  • Abstract Number: 2466
    Epigenetic Traits Correlate with Clinical Activity in Juvenile Idiopathic Arthritis
  • Abstract Number: 1262
    Epigenome-Wide DNA Methylation Patterns Associated with Fatigue in Primary Sjögren’s Syndrome
  • Abstract Number: 3166
    Epistatic Interaction of Functional Inflammasome Genetic Variants in Determining the Risk of Gout
  • Abstract Number: 1683
    Epithelial Changes in Response to Tocilizumab Combined with Methotrexate in Rheumatoid Arthritis: Evaluated on Circulating Fragments of Type IV Collagen
  • Abstract Number: 1108
    Epratuzumab, a Monoclonal Antibody Targeting CD22 on B Cells, Stimulates the Phosphorylation of Upstream Inhibitory Signals of the B Cell Receptor
  • Abstract Number: 3130
    Epstein-Barr Virus Induces Activation of Infammatory Markers Via the TLR8 Transduction Pathway in Infected Scleroderma Monocytes
  • Abstract Number: 983
    ERAP1 Deficiency Protects HLA-B27 Transgenic Rats from Arthritis
  • Abstract Number: 482
    Erosions in the Foot at Baseline Are Predictive of Orthopedic Shoe Use after 10 Years of Treat to Target Therapy
  • Abstract Number: 2898
    Erythrocytes, Acanthocytes, and Proteins in Urine Reflect Lupus Nephritis Histology
  • Abstract Number: 1807
    Estimated Sodium and Potassium Intake Are Associated with Blood Pressure in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 767
    Estimating the Pre-Test Probability of Systemic Lupus Erythematosus By Utilizing Anti-Double Stranded DNA and Cell Bound Complement Activation Products Testing from Rheumatology Based Practices in the United States
  • Abstract Number: 1228
    Estimating Under-Diagnosis of Rheumatoid Arthritis in Primary Care Data from the UK Clinical Practice Research Datalink
  • Abstract Number: 3010
    Estrogens Inhibit the Profibrotic Effects of Transforming Growth Factor-Beta and Protect from the Development of Experimental Dermal Fibrosis
  • Abstract Number: 461
    Etanercept Has a Better Retention Rate at 10 Years Than Adalimumab in Patients with Rheumatoid Arthritis. Results from Rhumadata®: A Real-Life Clinical Database and Registry
  • Abstract Number: 2850
    Etanercept Treatment in Psoriatic Arthritis:  Need for Co-Medication?
  • Abstract Number: 643
    Ethnicity of Sjögren’s Syndrome
  • Abstract Number: 1506
    EULAR Recommendations for Cardiovascular Risk Management in Patients with Rheumatoid Arthritis and Other Inflammatory Joint Diseases – 2015 Update
  • Abstract Number: 485
    Evaluate the Dose Efficacy Response Relationship of Baricitinib in Patients with Rheumatoid Arthritis
  • Abstract Number: 1296
    Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team
  • Abstract Number: 2755
    Evaluating Pharmacokinetic Predictors of Tofacitinib Clinical Response in Rheumatoid Arthritis
  • Abstract Number: 76
    Evaluating Weather’s Effect on Fibromyalgia Patients Using the Revised Fibromyalgia Impact Questionnaire and the Brief Pain Inventory
  • Abstract Number: 853
    Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Granulomatosis with Polyangiitis in Large Healthcare Administrative Databases
  • Abstract Number: 3065
    Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Takayasu’s Arteritis in Large Healthcare Administrative Databases
  • Abstract Number: 3244
    Evaluation of a Self-Directed Walking Program in Hispanics with Arthritis
  • Abstract Number: 2663
    Evaluation of Anti-Cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice and Its Association with Disease Activity
  • Abstract Number: 1657
    Evaluation of Bone and Joint Proteins for Prognostic Association with Radiographic Progression and Disease Activity in Methotrexate Inadequate Responder Rheumatoid Arthritis Patients in a Sarilumab Phase 3 Study
  • Abstract Number: 1524
    Evaluation of Changes in Cardiovascular Risk Factors Among Patients with RA Prescribed Biologic Dmards
  • Abstract Number: 2310
    Evaluation of Fibromyalgia Syndrome in Patients Undergoing Peritoneal Dialysis
  • Abstract Number: 1601
    Evaluation of Glucose Metabolism in Rheumatic Patients: A Case Control Study
  • Abstract Number: 3089
    Evaluation of Learned Helplessness, Perceived Self-Efficacy and Functional Capacity in Patients with Fibromyalgia and Rheumatoid Arthritis
  • Abstract Number: 3050
    Evaluation of Olfactory Function in Behcet’s Disease
  • Abstract Number: 684
    Evaluation of Patient Acceptable Symptom State in Patients with Axial Spondylarthritis; Similar Thresholds for Radiographic and Non-Radiographic Subgroups
  • Abstract Number: 2748
    Evaluation of Patient-Reported Outcomes By Baseline Disease Duration: 6-Month Data from Two Clinical Trials of Patients with Early Rheumatoid Arthritis Treated with Abatacept
  • Abstract Number: 620
    Evaluation of Patients from the Non-Biologic Arms of Inflammatory Arthritis Clinical Trials Identifies Several Predictors of Remission, As Well As, Distinct Responder Subgroups
  • Abstract Number: 506
    Evaluation of Persistence and Outcomes in Patients Treated with TNF and Non-TNF Biologics Following Treatment Clinical Pathway in Rheumatoid Arthritis
  • Abstract Number: 3055
    Evaluation of Plasma Pentraxin-3 Level in Patients with Takayasu’s Arteritis
  • Abstract Number: 3210
    Evaluation of Sacroiliac Joint Radiographs in Patients with Chronic Low Back Pain: Is Erosion the Main Driver of Interreader Disagreement?
  • Abstract Number: 2991
    Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis
  • Abstract Number: 2604
    Evaluation of Serum Undercarboxylated Osteocalcin in Premenopausal Rheumatoid Arthritis Patients; Its Correlation with Disease Activity and Bone Mineral Density
  • Abstract Number: 769
    Evaluation of Soluble Alpha-Klotho in Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 2996
    Evaluation of Systemic Sclerosis Risk Genes in the Turkish Population
  • Abstract Number: 562
    Evaluation of T Helper Cell 1(Th1) – and T Helper Cell 17(Th17) – Associated Chemokines As Prognostic Biomarkers for Tumor Necrosis Factor (TNF) Inhibitor Therapy in Rheumatoid Arthritis (RA)
  • Abstract Number: 930
    Evaluation of Temporomandibular Joint Arthritis with Ultrasound in Juvenile Idiopathic Arthritis
  • Abstract Number: 2287
    Evaluation of the Fibromyalgia Rapid Screening Tool (FiRST) Questionnaire to Screen Fibromyalgia Associated with Inflammatory Rheumatic Disease
  • Abstract Number: 2651
    Evaluation of the Impact of Disease-Modifying Antirheumatic Drugs on Anti-Cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice
  • Abstract Number: 670
    Evaluation of the Predictive Value of Non-Specific Musculoskeletal Symptoms in Preclinical Phases of Psoriatic Arthritis
  • Abstract Number: 883
    Evaluation of Thiopurine Metabolites Monitoring in Patients Treated with Azathioprine for Rheumatic Diseases
  • Abstract Number: 289
    Evaluation of Usefulness of Krebs Von Den Lungen-6 As a Biomarker of Interstitial Lung Disease with Polymyositis and Dermatomyositis Including in the Short Time Course after Treatment
  • Abstract Number: 2082
    Evaluations of Social Support Are Associated with Well-Being Outcomes in Women with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 194
    Events Upstream of Caspase-1 Activation in NLRP3-Mediated Cell Death in NOMID
  • Abstract Number: 1617
    Evidence for Citrullinated Inhibitor of DNA Binding 1 (Id1) As a Novel Autoantigen Candidate in Rheumatoid Arthritis
  • Abstract Number: 3123
    Evidence of Altered Blood Brain Barrier Permeability in Systemic Lupus Erythematosus Using Magnetic Resonance Imaging
  • Abstract Number: 2838
    Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target?
  • Abstract Number: 2453
    Evidence-Based Decision Support for Pediatric Rheumatology Reduces Diagnostic Errors, with the Potential to Reduce Capacity Shortage
  • Abstract Number: 2936
    Evolution of Disease Burden over 7 Years in a Multicentre Inception SLE Cohort
  • Abstract Number: 2450
    Examination of the Clinical Significance of 14-3-3 Eta in Juvenile Idiopathic Arthritis
  • Abstract Number: 3261
    Examining the Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients with Breast Cancer
  • Abstract Number: 2973
    Exercise Intolerance Evaluated By Invasive Cardiopulmonary Exercise Testing in Connective Tissue Disease: Beyond Pulmonary Hypertension
  • Abstract Number: 1808
    Exercise Is Associated with Improved Cardiometabolic Risk Factors in Patients with SLE
  • Abstract Number: 1889
    Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
  • Abstract Number: 3001
    Exome Sequencing for Identification of Potential Causal Variants for Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 1856
    Exosomes from Patients with Active Systemic Lupus Erythematosus Induce a Strong Inflammatory Response
  • Abstract Number: 1055
    Expansions of Salivary Gland CD4+ T Cells from Sjögren’s Syndrome Patients: Single-Cell Repertoire Analysis and Correlation with Clinical Measures of Disease
  • Abstract Number: 2421
    Experience with Adalimumab for Treatment of 568 Juvenile Idiopathic Arthritis Patients in the German JIA Biologics Register
  • Abstract Number: 2437
    Experience with Tocilizumab for Treatment of 56 Children with Systemic Juvenile Idiopathic Arthritis in the German JIA Biologics Register
  • Abstract Number: 124
    Experiences with a Structured Questionnaire for Administrative Personnel to Discriminate Urgent and Non-Urgent Rheumatic Patients Referred from Primary to Secondary Care
  • Abstract Number: 142
    Exploration of General Practioners’ Difficulties with Methotrexate and Anti-TNF Therapies in Routine Practice
  • Abstract Number: 78
    Exploratory Analysis of Somatic Symptoms in Fibromyalgia By Multidimensional Scaling and Latent Class Analysis
  • Abstract Number: 2127
    Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Subclinical Coronary Atherosclerosis Is Higher Among Rheumatoid Arthritis Patients with the Lowest Circulating Low Density Lipoprotein Concentrations Compared with Controls
  • Abstract Number: 837
    Exposure to ACE Inhibitors Prior to Onset of Scleroderma Renal Crisis Is Not Associated with Increased Risk of Mortality in a Large Retrospective Cohort Study
  • Abstract Number: 1166
    Expression and Function of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (PIM-1) Kinase in Rheumatoid Arthritis Fibroblast-like Synoviocytes
  • Abstract Number: 590
    Expression Levels of Selected Genes May Predict Response to TNF Alpha Blockers or Rituximab in the Individual Rheumatoid Arthritis Patient
  • Abstract Number: 22
    Expression of High Mobility Group Box 1 Protein and the Receptor for Advanced Glycation End Products in Primary Gouty Arthritis
  • Abstract Number: 813
    Expression of Inducible Costimulator Ligand (ICOSL) on CD4+ T Cells in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2787
    Expression of Interferons Lambda in Salivary Glands of Patients with Sjögren’s Syndrome
  • Abstract Number: 1613
    Expression of the Genes Facilitating Methotrexate Action within Rheumatoid Subcutaneous Nodules
  • Abstract Number: 1145
    Expression of Xylosyltransferase-1 Is Modulated By Fibronectin Fragment in Human Articular Chondrocytes
  • Abstract Number: 880
    Extra-Corporeal Membrane Oxygenation and Diffuse Alveolar Haemorrhage: A Single Centre Case Series and Analysis of the ELSO Database
  • Abstract Number: 1244
    Extracellular MicroRNAs in Synovial Fluid Reveal a Marked Proliferative Signature in Patients with Antibiotic-Refractory Lyme Arthritis
  • Abstract Number: 2211
    Extracellular Vesicles from Cow Milk Accelerate Osteoblast Differentiation into Osteocytes, However, Type I Collagen Synthesis Is Reduced and Bone Matrix Organization Is Impaired
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.